tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

RXRX Stock Latest News

Recursion needs ‘definitive wins’ to validate platform, says JPMorgan
The FlyRecursion needs ‘definitive wins’ to validate platform, says JPMorgan
5d ago
RXRX
Recursion Pharmaceuticals Showcases Progress at JP Morgan Conference
PremiumCompany Announcements
Recursion Pharmaceuticals Showcases Progress at JP Morgan Conference
5d ago
8K
RXRX
Cathie Wood’s ARK Investment buys 653K shares of Recursion Pharmaceuticals today
PremiumThe Fly
Cathie Wood’s ARK Investment buys 653K shares of Recursion Pharmaceuticals today
10d ago
RXRX
Recursion Pharmaceuticals price target lowered to $10 from $12 at KeyBanc
PremiumThe Fly
Recursion Pharmaceuticals price target lowered to $10 from $12 at KeyBanc
10d ago
RXRX
Recursion announces two oncology drugs advancing to clinical trials
PremiumThe Fly
Recursion announces two oncology drugs advancing to clinical trials
11d ago
RXRX
Recursion Pharmaceuticals price target lowered to $10 from $12 at BofA
PremiumThe FlyRecursion Pharmaceuticals price target lowered to $10 from $12 at BofA
11d ago
RXRX
Recursion Pharmaceuticals CFO Ben Taylor to Join Exscientia
Premium
Company Announcements
Recursion Pharmaceuticals CFO Ben Taylor to Join Exscientia
2M ago
8K
RXRX
Recursion Pharmaceuticals call volume above normal and directionally bullish
Premium
The Fly
Recursion Pharmaceuticals call volume above normal and directionally bullish
2M ago
RXRX
Recursion Pharmaceuticals’ (RXRX) Bold Acquisition Places it as an Industry Leader
PremiumMarket News
Recursion Pharmaceuticals’ (RXRX) Bold Acquisition Places it as an Industry Leader
2M ago
NVDA
Recursion announces first patient dosed in Phase 1/2 trial of REC-1245
PremiumThe Fly
Recursion announces first patient dosed in Phase 1/2 trial of REC-1245
2M ago
RXRX
Unusually active option classes on open December 2nd
PremiumThe Fly
Unusually active option classes on open December 2nd
2M ago
ZS
CNM
Cathie Wood’s ARK Investment buys 383K shares of Recursion Pharmaceuticals today
PremiumThe Fly
Cathie Wood’s ARK Investment buys 383K shares of Recursion Pharmaceuticals today
2M ago
RXRX
Unusually active option classes on open November 20th
PremiumThe FlyUnusually active option classes on open November 20th
2M ago
U
CVS
Recursion Pharmaceuticals’ Strategic Acquisition and Leadership Changes
Premium
Company Announcements
Recursion Pharmaceuticals’ Strategic Acquisition and Leadership Changes
2M ago
8K
RXRX
Recursion, Exscientia officially combine to advance drug discovery
Premium
The Fly
Recursion, Exscientia officially combine to advance drug discovery
2M ago
EXAI
RXRX
Recursion Pharmaceuticals call volume above normal and directionally bullish
PremiumThe Fly
Recursion Pharmaceuticals call volume above normal and directionally bullish
2M ago
RXRX
Recursion, Exscientia shareholders approve proposed combination
PremiumThe Fly
Recursion, Exscientia shareholders approve proposed combination
2M ago
EXAI
RXRX
Recursion Pharmaceuticals Reports Q3 2024 Earnings and Strategic Milestones
PremiumCompany Announcements
Recursion Pharmaceuticals Reports Q3 2024 Earnings and Strategic Milestones
2M ago
RXRX
Closing Bell Movers: AppLoving up 29% after Q3 earnings beat
PremiumThe Fly
Closing Bell Movers: AppLoving up 29% after Q3 earnings beat
2M ago
Z
DV
Recursion Pharmaceuticals reports Q3 EPS (34c), consensus (35c)
PremiumThe FlyRecursion Pharmaceuticals reports Q3 EPS (34c), consensus (35c)
2M ago
RXRX
Recursion Pharmaceuticals Advances Drug Discovery and Partnerships
Premium
Company Announcements
Recursion Pharmaceuticals Advances Drug Discovery and Partnerships
2M ago
8K
RXRX
Cathie Wood’s ARK Investment buys 106K shares of Recursion Pharmaceuticals today
Premium
The Fly
Cathie Wood’s ARK Investment buys 106K shares of Recursion Pharmaceuticals today
2M ago
RXRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >